Related Experiment Video
Updated: Jul 3, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Finding a policy solution to India's diabetes epidemic
Karen Siegel1, K M Venkat Narayan, Sanjay Kinra
1MATRIX Public Health Solutions Inc. New Haven, Connecticut, USA. siegel@matrixphc.com
Health Affairs (Project Hope)
|July 9, 2008
Summary
Diabetes in India is a growing epidemic, affecting millions of working-age individuals. Urgent, collaborative strategies are needed to mitigate the severe economic impact and manage this public health crisis effectively.
Area of Science:
- Public Health
- Epidemiology
- Health Economics
Background:
- Diabetes prevalence in India is rapidly increasing, with 35 million cases currently and projections to exceed 70 million by 2025.
- The epidemic disproportionately impacts the working-age population, posing a significant threat to India's economic development.
- The economic consequences of unchecked diabetes growth could be devastating for India's emerging economy.
Purpose of the Study:
- To analyze the key drivers fueling the diabetes epidemic in India.
- To critically evaluate existing policies and healthcare practices for diabetes management in India.
- To propose actionable recommendations for policymakers to address the diabetes crisis.
Main Methods:
- Review of epidemiological data on diabetes prevalence and projections in India.
- Analysis of current national and regional policies related to diabetes prevention and control.
- Assessment of economic impact models concerning diabetes in India.
- Literature review on multisectoral and international collaboration strategies for non-communicable diseases.
Main Results:
- Identified key drivers contributing to the escalating diabetes epidemic in India.
- Highlighted gaps and limitations in current diabetes policies and implementation.
- Quantified the potential adverse economic impact on India's economy.
- Recognized the need for integrated approaches involving various sectors and international partners.
Conclusions:
- Multisectoral and international collaboration is essential for an effective diabetes control blueprint in India.
- Addressing diabetes requires a comprehensive strategy that considers policy, economic, and public health dimensions.
- Recommendations aim to guide policymakers by identifying opportunities and overcoming barriers in diabetes management.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...